Work

Select high risk genetic features predict earlier progression following chemotherapy in chronic lymphocytic leukemia: Prospective randomized trial (Intergroup E2997) to evaluate justification for risk-adapted therapy

Year: 2006

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2006.24.18_suppl.6521

Authors: M. R. Grever, G. W. Dewald, D. S. Neuberg, J. C. Reed, S. Kitada, I. W. Flinn, F. R. Appelbaum, R. A. Larson, M. S. Tallman, J. G. Gribben, J. C. Byrd

Institutions: Northwestern University, Mayo Clinic, Johns Hopkins University, Sanford Burnham Prebys Medical Discovery Institute, University of Chicago, Fred Hutch Cancer Center, Dana-Farber Cancer Institute, The Ohio State University

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2283270522

Cites:

Cited by: 1

Related to: 10